Ray Therapeutics, Inc. Alternatives & Competitors
7 companies similar to Ray Therapeutics, Inc. — Optogenetic Gene Therapy Company
Companies similar to Ray Therapeutics, Inc.
LambdaVision, Inc.
Leveraging Space to Restore Vision with a Protein-Based Artificial Retina
Beacon Therapeutics
Transforming Vision, Transforming Lives
CiRC Biosciences
A privately held, cell therapy company, developing treatments for serious diseases, with a...
Rival Readout
Competing with Ray Therapeutics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
GenSight Biologics
Applying pathbreaking science to transform the lives of patients with severe retinal neuro...
ONL Therapeutics
Helping patients see the future
Adverum Biotechnologies
We are on a global mission to establish gene therapy as a new standard of care for the lea...
About Ray Therapeutics, Inc.
Ray Therapeutics, Inc. (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Their studies have shown for the first time that their p...
Optogenetic Gene Therapy, Vision Restoration, Retinal Blindness, Age-related Macular Degeneration, Retinitis Pigmentosa, ChRown Optogenetic Protein, AAV Gene Therapy, Precision Therapy, Clinical Trials, Gene Therapy Manufacturer, Visual Acuity, Contrast Sensitivity, Visual Field, Preclinical Stage
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ray Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ray Therapeutics, Inc. on 9 Jun 2026. The 7 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.